Neuronetics Stock Options
| STIM Stock | USD 2.09 0.11 5.00% |
Neuronetics' latest option contracts expiring on March 20th 2026 are carrying combined implied volatility of 2.07 with a put-to-call open interest ratio of 424.0 over 14 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on March 20th 2026. The total put volume is at 2.0.
Open Interest Against March 20th 2026 Option Contracts
2026-03-20
The chart above shows Neuronetics' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Neuronetics' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Neuronetics' option, there is no secondary market available for investors to trade.
Neuronetics Maximum Pain Price Across 2026-03-20 Option Contracts
Max pain occurs when Neuronetics' market makers reach a net positive position across all Neuronetics' options at a strike price where option holders stand to lose the most money. By contrast, Neuronetics' option sellers may reap the most after selling more options than buying, causing them to expire worthless.
In The Money vs. Out of Money Option Contracts on Neuronetics
Analyzing Neuronetics' in-the-money options over time can help investors to take a profitable long position in Neuronetics regardless of its overall volatility. This is especially true when Neuronetics' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Neuronetics' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Neuronetics' stock while costing only a fraction of its price.
Please note that buying 'in-the-money' options on Neuronetics lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Neuronetics' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Neuronetics contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Neuronetics Stock moves the wrong way.
Neuronetics In The Money Call Balance
When Neuronetics' strike price is surpassing the current stock price, the option contract against Neuronetics stock is said to be in the money. When it comes to buying Neuronetics' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Neuronetics are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Neuronetics Current Options Market Mood
Neuronetics' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Neuronetics Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Neuronetics' options investors are not very successful. Neuronetics' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Neuronetics contract
Base on the Rule 16, the options market is currently suggesting that Neuronetics will have an average daily up or down price movement of about 0.13% per day over the life of the 2026-03-20 option contract. With Neuronetics trading at USD 2.09, that is roughly USD 0.002704. If you think that the market is fully incorporating Neuronetics' daily price movement you should consider buying Neuronetics options at the current volatility level of 2.07%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Neuronetics | Build AI portfolio with Neuronetics Stock |
Purchasing Neuronetics options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Neuronetics calls. Remember, the seller must deliver Neuronetics stock to the call owner when a call is exercised.
Neuronetics Option Chain
When Neuronetics' strike price is surpassing the current stock price, the option contract against Neuronetics stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Neuronetics' option chain is a display of a range of information that helps investors for ways to trade options on Neuronetics. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Neuronetics. It also shows strike prices and maturity days for a Neuronetics against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | STIM260320C00007500 | 0 | 7.5 | 0.0 - 0.75 | 0.75 | |
Call | STIM260320C00005000 | 0 | 5.0 | 0.0 - 0.45 | 0.45 | |
Call | STIM260320C00002500 | 1 | 2.5 | 0.15 - 0.45 | 0.2 | Out |
Call | STIM260320C00002000 | 0 | 2.0 | 0.2 - 0.85 | 0.45 | In |
Call | STIM260320C00001500 | 0 | 1.5 | 0.5 - 1.2 | 0.5 | In |
Call | STIM260320C00001000 | 0 | 1.0 | 0.7 - 1.6 | 0.7 | In |
Call | STIM260320C00000500 | 0 | 0.5 | 1.1 - 2.05 | 1.1 | In |
Put | STIM260320P00007500 | 0 | 7.5 | 4.8 - 5.9 | 4.8 | In |
Put | STIM260320P00005000 | 0 | 5.0 | 2.3 - 3.4 | 2.3 | In |
Put | STIM260320P00002500 | 0 | 2.5 | 0.35 - 1.25 | 0.35 | In |
Put | STIM260320P00002000 | 0 | 2.0 | 0.1 - 0.95 | 0.1 | |
Put | STIM260320P00001500 | 0 | 1.5 | 0.0 - 0.75 | 0.75 | |
Put | STIM260320P00001000 | 0 | 1.0 | 0.05 - 1.05 | 0.09 | |
Put | STIM260320P00000500 | 424 | 0.5 | 0.0 - 0.1 | 0.05 | Out |
Neuronetics Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Neuronetics Total Stockholder Equity
Total Stockholder Equity |
|
Neuronetics Corporate Management
| MBA CMA | Chief Officer | Profile | |
| Lisa MetznerRosas | Senior Officer | Profile | |
| Andrew Macan | Gen VP | Profile | |
| Claire Sears | VP Marketing | Profile | |
| Rick Grubbs | Senior Accounts | Profile | |
| Cory Anderson | Senior Clinical | Profile | |
| Kara Thornton | VP Director | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Neuronetics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Will Health Care Equipment & Supplies sector continue expanding? Could Neuronetics diversify its offerings? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Neuronetics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.83) | Revenue Per Share | Quarterly Revenue Growth 1.013 | Return On Assets | Return On Equity |
Neuronetics's market price often diverges from its book value, the accounting figure shown on Neuronetics's balance sheet. Smart investors calculate Neuronetics' intrinsic value—its true economic worth—which may differ significantly from both market price and book value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Since Neuronetics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.